These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2069378)
1. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Allendoerfer R; Marquis AJ; Rinaldi MG; Graybill JR Antimicrob Agents Chemother; 1991 Apr; 35(4):726-9. PubMed ID: 2069378 [TBL] [Abstract][Full Text] [Related]
2. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Larsen RA; Leal MA; Chan LS Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908 [TBL] [Abstract][Full Text] [Related]
3. Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis. Reents SB; Powell G DICP; 1990 Sep; 24(9):885. PubMed ID: 2260351 [No Abstract] [Full Text] [Related]
4. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. Craven PC; Graybill JR J Infect Dis; 1984 Apr; 149(4):584-90. PubMed ID: 6327836 [TBL] [Abstract][Full Text] [Related]
5. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. Diamond DM; Bauer M; Daniel BE; Leal MA; Johnson D; Williams BK; Thomas AM; Ding JC; Najvar L; Graybill JR; Larsen RA Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927 [TBL] [Abstract][Full Text] [Related]
6. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model. Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852 [TBL] [Abstract][Full Text] [Related]
7. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Larsen RA; Bauer M; Thomas AM; Graybill JR Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793 [TBL] [Abstract][Full Text] [Related]
8. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Nguyen MH; Najvar LK; Yu CY; Graybill JR Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879 [TBL] [Abstract][Full Text] [Related]
9. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Ding JC; Bauer M; Diamond DM; Leal MA; Johnson D; Williams BK; Thomas AM; Najvar L; Graybill JR; Larsen RA Antimicrob Agents Chemother; 1997 Jul; 41(7):1589-93. PubMed ID: 9210691 [TBL] [Abstract][Full Text] [Related]
10. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole. Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832 [No Abstract] [Full Text] [Related]
11. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602 [TBL] [Abstract][Full Text] [Related]
12. Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis. Shindo K; Mizuno T; Matsumoto Y; Hashimoto Y; Matsumura M; Ito A; Shionoiri H DICP; 1989 Sep; 23(9):672-4. PubMed ID: 2800581 [TBL] [Abstract][Full Text] [Related]
13. Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. Shindo K Drugs Exp Clin Res; 1990; 16(7):327-32. PubMed ID: 1965500 [TBL] [Abstract][Full Text] [Related]
14. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Sloan D; Dlamini S; Paul N; Dedicoat M Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis. Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR mBio; 2019 May; 10(3):. PubMed ID: 31138748 [No Abstract] [Full Text] [Related]
16. Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. Buxton MJ; Dubois DJ; Turner RR; Sculpher MJ; Robinson PA; Searcy C J Infect; 1991 Jul; 23(1):17-31. PubMed ID: 1885910 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Schwarz P; Dromer F; Lortholary O; Dannaoui E Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675 [TBL] [Abstract][Full Text] [Related]
18. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. Jaruratanasirikul S Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873 [TBL] [Abstract][Full Text] [Related]
19. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis. Yao ZW; Lu X; Shen C; Lin DF Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039 [TBL] [Abstract][Full Text] [Related]